$CSLR
Complete Solaria, Inc. Stock $cslr

$cslr Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023087084 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$24.59M	$42.30M	$0.00
YoY Change
Cost Of Revenue	$18.35M	$33.43M
YoY Change		304.48%
Gross Profit	$6.236M	$8.863M
YoY Change		121.91%
Gross Profit Margin	25.36%	20.95%
Selling, General & Admin	$2.214M	$34.09M	$681.8K
YoY Change	224.72%	-5099.63%
% of Gross Profit	35.5%	384.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	-$1.406M	$2.028M
YoY Change
% of Gross Profit	-22.55%	22.88%
Operating Expenses	$17.31M	$34.09M	$2.580M
YoY Change	570.98%	-17536.32%
Operating Profit	-$11.08M	-$25.23M
YoY Change		-13002.88%
Interest Expense	$1.902M	-$6.951M	$2.801M
YoY Change	-32.1%	-586.48%
% of Operating Profit
Other Income/Expense, Net	-$38.00M	$9.701M	-$1.236M
YoY Change	2973.88%	202.27%
Pretax Income	-$50.97M	-$22.48M	-$743.8K
YoY Change	6753.46%	-760.09%
Income Tax	-$1.000K	$0.00
% Of Pretax Income
Net Earnings	-$206.9M	-$35.02M	-$743.8K
YoY Change	27715.32%	-1128.65%
Net Earnings / Revenue	-841.33%	-82.8%
Basic Earnings Per Share	-$5.20	-$0.41
Diluted Earnings Per Share	-$5.19	-$0.81	-$0.02
COMMON SHARES
Basic Shares Outstanding	39.82M shares	27.67M shares
Diluted Shares Outstanding	39.83M shares	27.67M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.661M	$2.545M	$72.92K
YoY Change	2177.84%	1400.94%
Cash & Equivalents	$1.661M	$2.545M	$72.92K
Short-Term Investments
Other Short-Term Assets	$9.947M	$15.03M	$120.7K
YoY Change	8142.46%	4517.61%
Inventory	$12.50M	$7.977M	$13.06M
Prepaid Expenses			$120.7K
Receivables	$26.00M	$24.26M	$27.72M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$50.11M	$49.81M	$193.6K
YoY Change	25785.33%	9963.17%	-80.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.185M	$5.640M	$3.476M
YoY Change	20.4%		97.72%
Goodwill
YoY Change
Intangibles	$0.00		$42.61M
YoY Change	-100.0%
Long-Term Investments	$3.500M		$349.9M
YoY Change	-99.0%
Other Assets	$198.0K	$9.127M	$0.00
YoY Change
Total Long-Term Assets	$21.91M	$175.3M	$349.9M
YoY Change	-93.74%	-49.5%	1.36%
TOTAL ASSETS
Total Short-Term Assets	$50.11M	$49.81M	$193.6K
Total Long-Term Assets	$21.91M	$175.3M	$349.9M
Total Assets	$72.02M	$225.1M	$350.1M
YoY Change	-79.43%	-35.24%	1.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.57M	$15.07M	$4.858M
YoY Change	199.92%	437.09%
Accrued Expenses	$19.28M	$18.04M
YoY Change
Deferred Revenue	$2.423M
YoY Change
Short-Term Debt	$27.93M	$27.16M	$828.6K
YoY Change	3271.23%	5534.65%
Long-Term Debt Due	$29.19M
YoY Change
Total Short-Term Liabilities	$107.4M	$74.54M	$5.687M
YoY Change	1788.23%	2166.84%	120.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$68.32M	$0.00
YoY Change
Other Long-Term Liabilities	$15.42M	$5.900M	$5.997M
YoY Change	157.16%	-57.89%
Total Long-Term Liabilities	$15.42M	$5.900M	$5.997M
YoY Change	157.16%	-57.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$107.4M	$74.54M	$5.687M
Total Long-Term Liabilities	$15.42M	$5.900M	$5.997M
Total Liabilities	$122.8M	$152.8M	$11.68M
YoY Change	951.04%	783.02%	-49.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$327.3M		-$17.55M
YoY Change	1764.99%		-19.95%
Common Stock	$7.000K		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$50.78M	$72.37M	-$11.49M
YoY Change
Total Liabilities & Shareholders Equity	$72.02M	$225.1M	$350.1M
YoY Change	-79.43%	-35.24%	1.13%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$206.9M	-$35.02M	-$743.8K
YoY Change	27715.32%	-1128.65%
Depreciation, Depletion And Amortization	-$1.406M	$2.028M
YoY Change
Cash From Operating Activities	-$20.14M	-$26.29M	-$321.6K
YoY Change	6162.48%	10153.91%
INVESTING ACTIVITIES
Capital Expenditures	$529.0K	$1.005M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$8.145M	-$236.2M	$0.00
YoY Change
Cash From Investing Activities	-$530.0K	-$237.2M	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	19.77M	261.5M	225.0K
YoY Change	8686.22%
NET CHANGE
Cash From Operating Activities	-20.14M	-26.29M	-321.6K
Cash From Investing Activities	-530.0K	-237.2M	0.000
Cash From Financing Activities	19.77M	261.5M	225.0K
Net Change In Cash	-903.0K	-1.988M	-96.63K
YoY Change	834.49%	675.38%
FREE CASH FLOW
Cash From Operating Activities	-$20.14M	-$26.29M	-$321.6K
Capital Expenditures	$529.0K	$1.005M
Free Cash Flow	-$20.67M	-$27.30M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-10-01
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40117
	dei	Entity Registrant Name EntityRegistrantName	COMPLETE SOLARIA, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	93-2279786
	dei	Entity Address Address Line1 EntityAddressAddressLine1	45700 Northport Loop East
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
	dei	City Area Code CityAreaCode	(510)
	dei	Local Phone Number LocalPhoneNumber	270-2507
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43176577	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1661000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4409000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10425000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5396000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26003000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27717000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	12503000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	13059000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9947000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10071000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	50114000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	55256000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	3758000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	3907000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4185000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3476000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1465000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2182000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	198000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1330000	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	12299000	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	162032000	usd
CY2023Q4	us-gaap	Assets Assets	72019000	usd
CY2022Q4	us-gaap	Assets Assets	228183000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14571000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14474000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	26674000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	19830000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2421000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5407000	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	29194000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107380000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60114000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3416000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3214000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10240000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	14152000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	25204000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3434000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	976000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	790000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1274000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	122802000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	122902000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19932429	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19932429	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	276438000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	190624000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	51000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-327279000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85373000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-50783000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	105281000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72019000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	228183000	usd
CY2023Q4	us-gaap	Revenues Revenues	24590000	usd
CY2022Q3	us-gaap	Revenues Revenues	12260000	usd
	us-gaap	Revenues Revenues	66887000	usd
	us-gaap	Revenues Revenues	48974000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	18354000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	8266000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	51788000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	33792000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	6236000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	3994000	usd
	us-gaap	Gross Profit GrossProfit	15099000	usd
	us-gaap	Gross Profit GrossProfit	15182000	usd
CY2023Q4	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	8755000	usd
CY2022Q3	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	3572000	usd
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	23221000	usd
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	15694000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2214000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1604000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5216000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4607000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6345000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2027000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22965000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6194000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	17314000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	7203000	usd
	us-gaap	Operating Expenses OperatingExpenses	51402000	usd
	us-gaap	Operating Expenses OperatingExpenses	26495000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-11078000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3209000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-36303000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11313000	usd
	us-gaap	Interest Expense InterestExpense	8870000	usd
	us-gaap	Interest Expense InterestExpense	2672000	usd
CY2023Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	26000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28302000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3180000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-50974000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4146000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73449000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10805000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-50973000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4146000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-73448000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10809000	usd
CY2023Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-8404000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-20953000	usd
CY2023Q4	fact	Impairment Loss From Discontinued Operations ImpairmentLossFromDiscontinuedOperations	-147505000	usd
	fact	Impairment Loss From Discontinued Operations ImpairmentLossFromDiscontinuedOperations	-147505000	usd
CY2023Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-155909000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-168458000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-206882000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4146000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-241906000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10809000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	10000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	24000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-206872000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4146000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-241882000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10809000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.28
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.31
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.33
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.83
CY2023Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-3.92
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-9.92
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.2
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-14.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39821078	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13431410	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16969979	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13053367	shares
	us-gaap	Net Income Loss NetIncomeLoss	-241906000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10809000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-168458000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-73448000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10809000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2321000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	217000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4009000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	76000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	717000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	304000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3235000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	622000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	463000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4269000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	716000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2144000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3091000	usd
	fact	Issuance Of Forward Purchase Agreement IssuanceOfForwardPurchaseAgreement	76000	usd
	fact	Change In Fair Value Of Convertible Note ChangeInFairValueOfConvertibleNote	6661000	usd
	fact	Loss On Cs Solis Debt Extinguishment LossOnCSSolisDebtExtinguishment	10338000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-26314000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	142000	usd
	fact	Accretion Of Longterm Debt In Cs Solis AccretionOfLongtermDebtInCSSolis	2493000	usd
	fact	Accretion Of Longterm Debt In Cs Solis AccretionOfLongtermDebtInCSSolis	2581000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	35490000	usd
	fact	Issuance Of Common Stock Bonuses In Connection With The Merger IssuanceOfCommonStockBonusesInConnectionWithTheMerger	2394000	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	52000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11823000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3036000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3896000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5047000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8326000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-504000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1132000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	15000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4372000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	190000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1587000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2056000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-359000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-316000	usd
	fact	Warranty Provision Noncurrent WarrantyProvisionNoncurrent	255000	usd
	fact	Warranty Provision Noncurrent WarrantyProvisionNoncurrent	-584000	usd
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-1766000	usd
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-231000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-47152000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-17197000	usd
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	190000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46962000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17197000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	29000	usd
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	1505000	usd
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	1048000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1534000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1048000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	14102000	usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-9653000	usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-9507000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	17750000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3500000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	500000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	57000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	28000	usd
	fact	Proceeds From Merger And Pipe Financing ProceedsFromMergerAndPIPEFinancing	4219000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	15600000	usd
	fact	Payments For Issuance Of Series D Redeemable Convertible Preferred Stock PaymentsForIssuanceOfSeriesDRedeemableConvertiblePreferredStock	1317000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45575000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13704000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2897000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4541000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8316000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5276000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5419000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	735000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1602000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-38000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	245000	usd
	fact	Carlyle Warrant Modification CarlyleWarrantModification	10862000	usd
	fact	Reclassification Of Liabilityclassified Warrants To Equityclassified Warrants ReclassificationOfLiabilityclassifiedWarrantsToEquityclassifiedWarrants	30625000	usd
	fact	Issuance Of Common Stock Warrants IssuanceOfCommonStockWarrants	202000	usd
	fact	Issuance Of Common Stock Warrants IssuanceOfCommonStockWarrants	3447000	usd
	fact	Issuance Of Series D Redeemable Convertible Preferred Stock Upon Conversion Of Safe IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfSAFE	6550000	usd
	fact	Issuance Of Series D Redeemable Convertible Preferred Stock Upon Conversion Of Convertible Debt IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfConvertibleDebt	10680000	usd
	fact	Issuance Of Convertible Notes Into Common Stock IssuanceOfConvertibleNotesIntoCommonStock	21561000	usd
	fact	Issuance Of Convertible Notes Issued To Related Parties Into Common Stock IssuanceOfConvertibleNotesIssuedToRelatedPartiesIntoCommonStock	19390000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	155630000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	35490000	usd
	fact	Issuance Of Common Stock In Connection With The Merger IssuanceOfCommonStockInConnectionWithTheMerger	2394000	usd
	fact	Recapitalization Of Legacy Complete Solaria Common Stock Into Complete Solaria Common Stock RecapitalizationOfLegacyCompleteSolariaCommonStockIntoCompleteSolariaCommonStock	1000	usd
	fact	Reclassification Of Investor Related To Pipe Funds ReclassificationOfInvestorRelatedToPIPEFunds	3500000	usd
	fact	Forward Purchase Agreements ForwardPurchaseAgreements	1161512	shares
	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	10
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	15700000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	60000	shares
	fact	Subscription Agreements SubscriptionAgreements	120000	shares
	fact	Aggregate Gross Proceeds AggregateGrossProceeds	600000	usd
	fact	Reimbursing Sponsors ReimbursingSponsors	193976	shares
	fact	Counterparties Issued Additional CounterpartiesIssuedAdditional	150000	shares
CY2023Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	23256504	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	7784739	shares
CY2023Q4	us-gaap	Payable Common Stock Redeemed PayableCommonStockRedeemed	82200000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	4100000	usd
	us-gaap	Profit Loss ProfitLoss	10800000	usd
CY2023Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	327300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	1700000	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	4400000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b><i>(a)</i></b></td><td style="text-align: justify"><b><i>Use of Estimates</i></b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the allocation of the transaction price to identified performance obligations;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fair value of warrant liabilities;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value of assets acquired and liabilities assumed for business combinations;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the reserve methodology for inventory obsolescence;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the reserve methodology for product warranty;</span></td></tr> </table><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the reserve methodology for the allowance for credit losses; and</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value of the forward purchase agreements.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b><i>(b)</i></b></td><td style="text-align: justify"><b><i>Supply Chain Constraints and Risk</i></b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of the Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company has seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the COVID-19 pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the COVID-19 pandemic.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations.</p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1661000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4409000	usd
CY2023Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	3758000	usd
CY2022Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	3907000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5419000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	8316000	usd
CY2023Q4	us-gaap	Revenues Revenues	24590000	usd
CY2022Q3	us-gaap	Revenues Revenues	12260000	usd
	us-gaap	Revenues Revenues	66887000	usd
	us-gaap	Revenues Revenues	48974000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1000000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1300000	usd
CY2023Q4	fact	Deferred Commission DeferredCommission	5500000	usd
CY2022Q4	fact	Deferred Commission DeferredCommission	2800000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2500000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3900000	usd
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	19700000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	7683000	usd
	fact	Warrant Liabilities Public Warrants WarrantLiabilitiesPublicWarrants	1413000	usd
	fact	Warrant Liabilities Private Warrants WarrantLiabilitiesPrivateWarrants	1027000	usd
	fact	Working Capital Warrants WorkingCapitalWarrants	117000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6586000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	16826000	usd
CY2022Q4	us-gaap	Mandatorily Redeemable Preferred Stock Fair Value Disclosure MandatorilyRedeemablePreferredStockFairValueDisclosure	14152000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	14152000	usd
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2745879	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Description FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedDescription	The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1170000	usd
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	19658000	usd
	us-gaap	Subsidiary Or Equity Method Investee Cumulative Proceeds Received On All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions	9523000	usd
CY2023Q4	us-gaap	Temporary Equity Share Subscriptions TemporaryEquityShareSubscriptions	31041243	shares
	us-gaap	Stock Dividends Shares StockDividendsShares	19796221	shares
	fact	Legacy In Shares LegacyInShares	20034257	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	5460075	shares
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	45290553	shares
	us-gaap	Professional Fees ProfessionalFees	15800000	usd
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	5200000	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	10600000	usd
CY2023Q4	us-gaap	Cash Cash	5400000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	fact	Purchase Percentage PurchasePercentage	0.099	pure
	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	5
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2023Q4	us-gaap	Fair Value Hedge Assets At Fair Value FairValueHedgeAssetsAtFairValue	100000	usd
	us-gaap	Other General Expense OtherGeneralExpense	6700000	usd
CY2023Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	119400000	usd
	fact	Goodwill Periods GoodwillPeriods	P15Y
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	3774000	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	29048000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43100000	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	3497000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	6255000	usd
CY2023Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	5509000	usd
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	2838000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	941000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	978000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9947000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10071000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	4102000	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	30609000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-328000	usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-1561000	usd
CY2023Q4	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	2425000	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	6855000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	5681000	usd
	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	12572000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	8106000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	19427000	usd
CY2023Q4	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-8434000	usd
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-20988000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	31000	usd
	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	32000	usd
CY2023Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-8403000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-20956000	usd
CY2023Q4	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-1000	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	3000	usd
CY2023Q4	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-147505000	usd
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-147505000	usd
CY2023Q4	us-gaap	Gain Loss On Disposition Of Real Estate Discontinued Operations GainLossOnDispositionOfRealEstateDiscontinuedOperations	-155909000	usd
	us-gaap	Gain Loss On Disposition Of Real Estate Discontinued Operations GainLossOnDispositionOfRealEstateDiscontinuedOperations	-168458000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets DisposalGroupIncludingDiscontinuedOperationIntangibleAssets	12299	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets DisposalGroupIncludingDiscontinuedOperationIntangibleAssets	42610	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	119422	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	12299	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	162032	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7488000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5954000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	3303000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	2478000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	4185000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3476000	usd
CY2023Q4	us-gaap	Utilities Operating Expense Depreciation And Amortization UtilitiesOperatingExpenseDepreciationAndAmortization	300000	usd
	us-gaap	Utilities Operating Expense Depreciation And Amortization UtilitiesOperatingExpenseDepreciationAndAmortization	600000	usd
CY2023Q3	us-gaap	Utilities Operating Expense Depreciation And Amortization UtilitiesOperatingExpenseDepreciationAndAmortization	200000	usd
	us-gaap	Utilities Operating Expense Depreciation And Amortization UtilitiesOperatingExpenseDepreciationAndAmortization	400000	usd
CY2023Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	119400000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	119400000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	0	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	119400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43237000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-28083000	usd
CY2023Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	12299000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2855000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43237000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-627000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42610000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	738000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2228000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	100000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	100000	usd
CY2023Q4	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	3666000	usd
CY2022Q4	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	3940000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	1167000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	930000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	3554000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1914000	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	1391000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	972000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan	2175000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan	2400000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2955000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1853000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	931000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	1245000	usd
CY2023Q4	fact	Accrued Rebates And Credits AccruedRebatesAndCredits	-880000	usd
CY2022Q4	fact	Accrued Rebates And Credits AccruedRebatesAndCredits	-1076000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	720000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	958000	usd
CY2023Q4	fact	Revenue Warranty RevenueWarranty	918000	usd
CY2023Q4	fact	Deferred Underwriters Discount Payable DeferredUnderwritersDiscountPayable	3019000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	605000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	767000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4693000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3775000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	26674000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	19830000	usd
CY2023Q4	fact	Proceeds From Issuance Of Redeemable Convertible Preferred Stock1 ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1	-39000	usd
CY2022Q3	fact	Proceeds From Issuance Of Redeemable Convertible Preferred Stock1 ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1	-3000	usd
	fact	Proceeds From Issuance Of Redeemable Convertible Preferred Stock1 ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1	-9455000	usd
	fact	Proceeds From Issuance Of Redeemable Convertible Preferred Stock1 ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1	142000	usd
CY2023Q4	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	12689000	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	12689000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	-4170000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	-4170000	usd
	fact	Gain On Extinguishment Of Convertible Notes And Safe Agreements GainOnExtinguishmentOfConvertibleNotesAndSAFEAgreements	3235000	usd
CY2023Q4	fact	Loss On Extinguishment LossOnExtinguishment	10338000	usd
	fact	Loss On Extinguishment LossOnExtinguishment	10338000	usd
CY2023Q4	fact	Issuance Of Common Stock Bonus Shares In Connection With Merger IssuanceOfCommonStockBonusSharesInConnectionWithMerger	2394000	usd
	fact	Issuance Of Common Stock Bonus Shares In Connection With Merger IssuanceOfCommonStockBonusSharesInConnectionWithMerger	2394000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	76000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	76000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-6661000	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-6661000	usd
CY2023Q4	fact	Issuance Of Shares In Connection With The Forward Purchase Agreements IssuanceOfSharesInConnectionWithTheForwardPurchaseAgreements	35490000	usd
	fact	Issuance Of Shares In Connection With The Forward Purchase Agreements IssuanceOfSharesInConnectionWithTheForwardPurchaseAgreements	35490000	usd
CY2023Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-94000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	191000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	87000	usd
CY2023Q4	fact	Total Other Incomeexpense Net1 TotalOtherIncomeexpenseNet1	-38003000	usd
CY2022Q3	fact	Total Other Incomeexpense Net1 TotalOtherIncomeexpenseNet1	4000	usd
	fact	Total Other Incomeexpense Net1 TotalOtherIncomeexpenseNet1	-28302000	usd
	fact	Total Other Incomeexpense Net1 TotalOtherIncomeexpenseNet1	3180000	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	0	usd
	us-gaap	Interest Income Other InterestIncomeOther	1400000	usd
CY2023Q4	us-gaap	Interest Income Other InterestIncomeOther	700000	usd
CY2023Q4	us-gaap	Interest Income Other InterestIncomeOther	300000	usd
CY2023Q4	us-gaap	Interest Expense Other InterestExpenseOther	30700000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	27637266	shares
CY2023Q4	us-gaap	Employee Stock Ownership Plan Esop Deferred Shares EmployeeStockOwnershipPlanESOPDeferredShares	2628996	usd
CY2023Q4	fact	Stock Options And Rs Us Issued And Outstanding StockOptionsAndRSUsIssuedAndOutstanding	7013514	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8625023	shares
CY2023Q4	fact	Total Share Reserved TotalShareReserved	45904799	shares
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	173067	shares
	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.019	pure
CY2023Q4	fact	Warrant Vesting WarrantVesting	150000	shares
	fact	Warrant Liability WarrantLiability	20400000	usd
CY2023Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	9500000	usd
	us-gaap	Other Income OtherIncome	12700000	usd
	fact	Warrants Purchase Shares warrantsPurchaseShares	8625000	shares
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3434000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	15510000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	18944000	usd
CY2021Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	500000	usd
CY2021Q2	us-gaap	Financing Receivable Modification To Total Financing Receivables Excluding Accrued Interest Percent FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent	0.03	pure
CY2022Q1	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	500000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	0	usd
	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	100000	usd
	us-gaap	Financing Receivable Modification To Total Financing Receivables Excluding Accrued Interest Percent FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent	0.06	pure
CY2023Q4	us-gaap	Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee	0.80	pure
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	100000	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
CY2023Q4	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	62500	shares
	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	100000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	100000	usd
CY2021Q4	us-gaap	Members Equity MembersEquity	15000000	usd
CY2022Q1	fact	Repaid The Principal And Accrued Interest RepaidThePrincipalAndAccruedInterest	6700000	usd
CY2022Q4	srt	Interest Bearing Liabilities Average Rate Paid InterestBearingLiabilitiesAverageRatePaid	0.08	pure
CY2023Q4	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	300000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1000000	usd
	fact	Prime Rate Plus PrimeRatePlus	0.045	pure
CY2023Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1900000	usd
CY2022Q4	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.70	pure
CY2022Q4	us-gaap	Repayments Of Longterm Loans From Vendors RepaymentsOfLongtermLoansFromVendors	10000000	usd
CY2022Q4	us-gaap	Deposits Paid For Securities Borrowed At Carrying Value DepositsPaidForSecuritiesBorrowedAtCarryingValue	20000000	usd
	fact	Outstanding Net Debt Amount OutstandingNetDebtAmount	11700000	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	4100000	usd
CY2022	fact	Outstanding Net Debt Amount OutstandingNetDebtAmount	5600000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	100000	usd
CY2023Q4	fact	Recognized Interest Expense RecognizedInterestExpense	0	usd
	fact	Recognized Interest Expense RecognizedInterestExpense	3100000	usd
CY2023Q3	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	500000	usd
CY2023Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	100000	usd
CY2023Q4	us-gaap	Preferred Units Contributed Capital PreferredUnitsContributedCapital	25600000	usd
CY2023Q4	fact	Investment Dividend Payable Percentage InvestmentDividendPayablePercentage	0.25	pure
	fact	Exercisable Shares ExercisableShares	4132513	shares
	fact	Investment Description InvestmentDescription	The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
CY2023Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	28400000	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	31900000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	0	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	25200000	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1200000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2700000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	200000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	400000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	900000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	29100000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4970419	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.86
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M26D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	34180000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2164946	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.18
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67292	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	142218	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.46
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6925855	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.91
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2727000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6925855	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.91
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2727000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3037856	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	5.16
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2245000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	728600	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	155473	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.84
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	485468	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.07
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	87659	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.07
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	52167	shares
CY2023Q3	fact	Vested Shares Exercise Of Period VestedSharesExerciseOfPeriod	280412	shares
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Currencies FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentCurrencies	0.85	pure
CY2023Q4	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	2628996	usd
CY2023Q4	us-gaap	Variable Lease Cost VariableLeaseCost	100000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	300000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	100000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	200000	usd
CY2023Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	usd
CY2022Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	500000	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	800000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M9D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.152	pure
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-206882000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	263000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	743000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	592000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	477000	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2075000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	565000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1510000	usd
CY2023Q2	us-gaap	Payments For Reinsurance PaymentsForReinsurance	800000	usd
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	100000	usd
CY2023Q1	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	26400000	usd
CY2023Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	220	usd
CY2021Q3	us-gaap	Legal Fees LegalFees	6900000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	2000000	usd
CY2023Q3	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	6000000	usd
	us-gaap	Subadvisory Fees For Mutual Funds SubadvisoryFeesForMutualFunds	6000000	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	3500000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-50973000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4146000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-73448000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10809000	usd
CY2023Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-155909000	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-168458000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4146000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-241906000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10809000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39821078	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13431410	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16969979	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13053367	shares
CY2023Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.28
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.31
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.33
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.83
CY2023Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-3.92
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-9.92
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.2
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-14.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
	fact	Common Stock Warrants CommonStockWarrants	23626132	shares
CY2022	fact	Common Stock Warrants CommonStockWarrants	2000878	shares
CY2022	fact	Preferred Stock Warrants PreferredStockWarrants	488024	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	7013514	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2430949	shares
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	30639646	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4919851	shares
CY2020	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3300000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3600000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1400000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	12100000	usd
CY2023Q2	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	0.05	pure
CY2023Q2	us-gaap	Customer Funds CustomerFunds	3500000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3500000	usd
CY2023Q3	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	3500000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	12100000	usd
CY2023Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	12100000	usd
CY2023Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	5670000	shares
CY2023Q4	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	300000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5900000	usd
CY2023Q4	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	100000	usd
CY2023Q4	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	500000	usd
	fact	Change In Fair Value Of Convertible Note ChangeInFairValueOfConvertibleNote		usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent		usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45310553	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45310553	shares
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax		usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax		usd
CY2022Q3	fact	Impairment Loss From Discontinued Operations ImpairmentLossFromDiscontinuedOperations		usd
	fact	Impairment Loss From Discontinued Operations ImpairmentLossFromDiscontinuedOperations		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.31
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.83
CY2023Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.28
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.33
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-3.91
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-9.92
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-14.25
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.19
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13053367	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13431410	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16973195	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39830763	shares
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	fact	Issuance Of Forward Purchase Agreement IssuanceOfForwardPurchaseAgreement		usd
	fact	Loss On Cs Solis Debt Extinguishment LossOnCSSolisDebtExtinguishment		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	fact	Issuance Of Common Stock Bonuses In Connection With The Merger IssuanceOfCommonStockBonusesInConnectionWithTheMerger		usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense		usd
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	fact	Proceeds From Merger And Pipe Financing ProceedsFromMergerAndPIPEFinancing		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	fact	Payments For Issuance Of Series D Redeemable Convertible Preferred Stock PaymentsForIssuanceOfSeriesDRedeemableConvertiblePreferredStock		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	fact	Carlyle Warrant Modification CarlyleWarrantModification		usd
	fact	Reclassification Of Liabilityclassified Warrants To Equityclassified Warrants ReclassificationOfLiabilityclassifiedWarrantsToEquityclassifiedWarrants		usd
	fact	Issuance Of Series D Redeemable Convertible Preferred Stock Upon Conversion Of Safe IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfSAFE		usd
	fact	Issuance Of Series D Redeemable Convertible Preferred Stock Upon Conversion Of Convertible Debt IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfConvertibleDebt		usd
	fact	Issuance Of Convertible Notes Into Common Stock IssuanceOfConvertibleNotesIntoCommonStock		usd
	fact	Issuance Of Convertible Notes Issued To Related Parties Into Common Stock IssuanceOfConvertibleNotesIssuedToRelatedPartiesIntoCommonStock		usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	fact	Issuance Of Common Stock In Connection With The Merger IssuanceOfCommonStockInConnectionWithTheMerger		usd
	fact	Recapitalization Of Legacy Complete Solaria Common Stock Into Complete Solaria Common Stock RecapitalizationOfLegacyCompleteSolariaCommonStockIntoCompleteSolariaCommonStock		usd
	fact	Reclassification Of Investor Related To Pipe Funds ReclassificationOfInvestorRelatedToPIPEFunds		usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1		usd
CY2023Q4	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q4	fact	Revenue Warranty RevenueWarranty		usd
CY2022Q4	fact	Deferred Underwriters Discount Payable DeferredUnderwritersDiscountPayable		usd
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants		usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants		usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023Q4	fact	Gain On Extinguishment Of Convertible Notes And Safe Agreements GainOnExtinguishmentOfConvertibleNotesAndSAFEAgreements		usd
CY2022Q3	fact	Gain On Extinguishment Of Convertible Notes And Safe Agreements GainOnExtinguishmentOfConvertibleNotesAndSAFEAgreements		usd
	fact	Gain On Extinguishment Of Convertible Notes And Safe Agreements GainOnExtinguishmentOfConvertibleNotesAndSAFEAgreements		usd
CY2022Q3	fact	Loss On Extinguishment LossOnExtinguishment		usd
	fact	Loss On Extinguishment LossOnExtinguishment		usd
CY2022Q3	fact	Issuance Of Common Stock Bonus Shares In Connection With Merger IssuanceOfCommonStockBonusSharesInConnectionWithMerger		usd
	fact	Issuance Of Common Stock Bonus Shares In Connection With Merger IssuanceOfCommonStockBonusSharesInConnectionWithMerger		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
CY2022Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment		usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment		usd
CY2022Q3	fact	Issuance Of Shares In Connection With The Forward Purchase Agreements IssuanceOfSharesInConnectionWithTheForwardPurchaseAgreements		usd
	fact	Issuance Of Shares In Connection With The Forward Purchase Agreements IssuanceOfSharesInConnectionWithTheForwardPurchaseAgreements		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments		usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2023Q4	us-gaap	Notes Payable NotesPayable		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter		usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent		usd
CY2022Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic		usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13053367	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13431410	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16973195	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39830763	shares
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.31
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.83
CY2023Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.28
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.33
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-3.91
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-9.92
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-14.25
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.19
	fact	Preferred Stock Warrants PreferredStockWarrants		shares
CY2023Q4	us-gaap	Dividends And Interest Paid DividendsAndInterestPaid		usd
	us-gaap	Dividends And Interest Paid DividendsAndInterestPaid		usd
CY2022Q3	us-gaap	Dividends And Interest Paid DividendsAndInterestPaid		usd
	us-gaap	Dividends And Interest Paid DividendsAndInterestPaid		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001838987

Files In Submission

Name	View Source	Status
fact-20231001_cal.xml	Edgar Link	unprocessable
0001213900-23-087084-index-headers.html	Edgar Link	pending
0001213900-23-087084-index.html	Edgar Link	pending
0001213900-23-087084.txt	Edgar Link	pending
0001213900-23-087084-xbrl.zip	Edgar Link	pending
f10q1023ex31-1_completesol.htm	Edgar Link	pending
f10q1023ex31-2_completesol.htm	Edgar Link	pending
f10q1023ex32-1_completesol.htm	Edgar Link	pending
f10q1023_completesol.htm	Edgar Link	pending
fact-20231001.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
fact-20231001_def.xml	Edgar Link	unprocessable
fact-20231001_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fact-20231001_pre.xml	Edgar Link	unprocessable
f10q1023_completesol_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSLR
Complete Solaria, Inc. Stock $cslr

2023 Q4 Form 10-Q Financial Statement

#000121390023087084 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSLR Complete Solaria, Inc. Stock $cslr

2023 Q4 Form 10-Q Financial Statement

#000121390023087084 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSLR
Complete Solaria, Inc. Stock $cslr